REGULATION OF CGMP DEPENDENT PROTEIN KINASE
REGULATION OF CGMP DEPENDENT PROTEIN KINASE
批准号:
2905374
负责人:
JACKIE David CORBIN
金额:
$31.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-09-01 至 2003-08-31
关键词:
SDS polyacrylamide gel electrophoresis animal tissue cGMP dependent protein kinase conformation cyclic AMP cyclic GMP dimer enzyme activity enzyme mechanism enzyme structure gas chromatography mass spectrometry high performance liquid chromatography laboratory rat messenger RNA phosphorylation protein isoforms protein sequence protein structure function proteolysis site directed mutagenesis swine
中文摘要
对cGMP作为第二信使的兴趣在#年急剧升级
最近几年。哺乳动物组织中cGMP的作用清单现在是
规模相当大,而且还在不断增长。CGMP依赖的蛋白激酶(PKG)
是cGMP的主要细胞内受体。澄清:
对PKG的生理调节是其长期目标
调查。除了被归因于PKG在
利钠肽、一氧化氮或鸟苷的调节作用
呼吸道和血管平滑肌松弛,抑制血小板
聚集和中性粒细胞脱颗粒,PKG也可能介导
这些药物和其他药物对基因表达的cGMP依赖效应,
氯化物在肠道和肾脏的转运,心脏的收缩能力,水
通过血管内皮细胞运输,骨吸收,
皮肤中的黑色素生成、长期的神经抑制和阿片类药物效应。
PKG的激活被认为是许多药理作用的原因
药物的作用,例如“PDE抑制剂”(例如,咖啡因,
罂粟碱)和硝基血管扩张剂(例如硝酸甘油)
用于缓解胸痛、哮喘、男性阳萎和高血
压力。PKG也可能介导某些特定因素引起的分泌性腹泻。
细菌肠毒素。PKG的重要性最近被认为是
通过认识到cAMP的一些作用是通过
PKG的交叉激活。
PKG-I-α和PKG-I-β的二聚化机制将是
采用诱变和蛋白水解法进行研究。原生和突变型PKG-I-
将使用Alpha和PKG-I-beta来定义
自我抑制结构域,并研究自我磷酸化。这个
负责激活每种异构体的自磷酸化位点(S)
将会被确认。与cGMP结合相关的构象变化
并将使用小角X射线测量自动磷酸化
散射、凝胶过滤和天然凝胶电泳法。PKG将成为
用作其他丝氨酸/苏氨酸和酪氨酸专一性的模型
由配体结合(例如,环)激活的蛋白激酶
核苷酸钙/钙调蛋白、胰岛素、生长因子)和
通过确定是否被cGMP-激活而实现自动磷酸化
结合或自动磷酸化会产生相同的酶构象。
我们将研究激活过程的分子机制。
天然凝胶电泳法,将不同的
PKG的自磷酸化物种和液-质联用
光谱将被用来确定这些物种是否存在于
完整的组织。PKG蛋白和mRNA水平的生理调节
将会被探索。这些调查的结果将涉及主要
通过PKG的cGMP信号转导方面。
英文摘要
Interest in cGMP as a second messenger has dramatically escalated in
recent years. The list of cGMP actions in mammalian tissues is now
quite large, and it is growing. The cGMP-dependent protein kinase (PKG)
is a major intracellular receptor for cGMP. Elucidation of the
physiological regulation of PKG is the long-term objective of this
investigation. In addition to the classical roles ascribed to PKG in
mediating effects of natriuretic peptides, nitric oxide or guanylins on
airway and vascular smooth muscle relaxation, inhibition of platelet
aggregation, and neutrophil degranulation, PKG may also mediate the
cGMP-dependent effects of these and other agents on gene expression,
chloride transport in intestine and kidney, heart contractility, water
transport through the vascular endothelium, bone resorption,
melanogenesis in skin, long-term nerve depression and opioid effects.
PKG activation is believed to account for many of the pharmacological
actions of medications such as "PDE inhibitors" (e.g., caffeine,
papaverine) and nitrovasodilators (e.g., nitroglycerin) which are used
for relief of chest pain, asthma, male impotence, and high blood
pressure. PKG may also mediate the secretory diarrhea caused by certain
bacterial enterotoxins. The importance of PKG has recently been
enhanced by the realization that some effects of cAMP are mediated by
cross-activation of PKG.
The mechanism of dimerizaiton of PKG-I-alpha and PKG-I-beta will be
studied using mutagenesis and proteolysis. Native and mutant PKG-I-
alpha and PKG-I-beta will be utilized to define functional elements of
the autoinhibitory domain and to study autophosphorylation. The
autophosphorylation site(s) responsible for activation of each isoform
will be identified. Conformational changes associated with cGMP binding
and autophosphorylation will be measured using small angle X-ray
scattering, gel filtration and native gel electrophoresis. PKG will be
used as a model for other serine/threonine- and tyrosine-specific
protein kinases that are activated by both ligand-binding (e.g., cyclic
nucleotides Ca2+/calmodulin, insulin, growth factors) and
autophosphorylation by determining whether or not activation by cGMP-
binding or autophosphorylation produces the same enzyme conformation.
The molecular mechanism of the activation processes will be examined.
Native gel electrophoresis, which separates the different
autophosphorylated species of the PKGs, and liquid chromatography-mass
spectrometry will be used to determine if these species are present in
intact tissues. Physiological regulation of PKG protein and mRNA levels
will be explored. Results of these investigations will address major
aspects of cGMP signaling through PKG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of PDE5 Regulation
-
批准号:6889205
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2001
-
负责人:JACKIE David CORBIN
-
依托单位:
Molecular Mechanisms of PDE5 Regulation
-
批准号:6736841
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2001
-
负责人:JACKIE David CORBIN
-
依托单位:
Molecular Mechanisms of PDE5 Regulation
-
批准号:6333849
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2001
-
负责人:JACKIE David CORBIN
-
依托单位:
Molecular Mechanisms of PDE5 Regulation
-
批准号:6517814
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2001
-
负责人:JACKIE David CORBIN
-
依托单位:
Molecular Mechanisms of PDE5 Regulation
-
批准号:6635309
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2001
-
负责人:JACKIE David CORBIN
-
依托单位:
REGULATION OF CGMP DEPENDENT PROTEIN KINASE
-
批准号:2859454
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1998
-
负责人:JACKIE David CORBIN
-
依托单位:
REGULATION OF CGMP DEPENDENT PROTEIN KINASE
-
批准号:2859554
-
项目类别:
-
资助金额:$0.92万
-
财政年份:1998
-
负责人:JACKIE David CORBIN
-
依托单位:
9TH INT'L CONFERENCE ON 2ND MESSENGERS & PHOSPHOPROTEINS
-
批准号:2192995
-
项目类别:
-
资助金额:$0.4万
-
财政年份:1995
-
负责人:JACKIE David CORBIN
-
依托单位:
9TH INT'L CONFERENCE ON 2ND MESSENGERS & PHOSPHOPROTEINS
-
批准号:2192996
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1995
-
负责人:JACKIE David CORBIN
-
依托单位:
FASEB SUMMER RESEARCH CONFERENCE: PROTEIN KINASES
-
批准号:3435131
-
项目类别:
-
资助金额:$0.15万
-
财政年份:1991
-
负责人:JACKIE David CORBIN
-
依托单位:
CGMP-BINDING PHOSPHODIESTERASE: REGULATORY MECHANISMS
-
批准号:3299350
-
项目类别:
-
资助金额:$27.32万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
DIFFERENT ISOZYMIC FORM OF CGMP-DEPENDENT PROTEIN KINASE
-
批准号:3240108
-
项目类别:
-
资助金额:$20.45万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
DIFFERENT ISOZYMIC FORM OF CGMP-DEPENDENT PROTEIN KINASE
-
批准号:3240111
-
项目类别:
-
资助金额:$21.04万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
Molecular Control of cGMP Signaling by PKGs and PDEs
-
批准号:7076192
-
项目类别:
-
资助金额:$38.69万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
Molecular Control of cGMP Signaling by PKGs and PDEs
-
批准号:6796777
-
项目类别:
-
资助金额:$37.35万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
CGMP-BINDING PHOSPHODIESTERASE: REGULATORY MECHANISMS
-
批准号:3299353
-
项目类别:
-
资助金额:$29.19万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
REGULATION OF CGMP DEPENDENT PROTEIN KINASE
-
批准号:2141160
-
项目类别:
-
资助金额:$28.2万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
Molecular Control of cGMP Signaling by PKGs and PDEs
-
批准号:6681336
-
项目类别:
-
资助金额:$36.26万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
REGULATION OF CGMP DEPENDENT PROTEIN KINASE
-
批准号:2518283
-
项目类别:
-
资助金额:$29.02万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
CGMP-BINDING PHOSPHODIESTERASE--REGULATORY MECHANISMS
-
批准号:2180756
-
项目类别:
-
资助金额:$32.81万
-
财政年份:1989
-
负责人:JACKIE David CORBIN
-
依托单位:
海外基金